Skip to main content

Table 3 Changes in outcome measures with Active+me (mean; 95% Confidence Intervals)

From: Changes in patient activation following cardiac rehabilitation using the Active+me digital healthcare platform during the COVID-19 pandemic: a cohort evaluation

Variable Baseline Follow-up P-Value Effect Size
PAM Scores✝ 65.5 (51.0 to 100.0) 70.2 (40.7 to 100.0) 0.039* 0.101
Patients with PAM Level 1 (%) 0 (0.0) 2 (4.3) 0.107
Patients with PAM Level 2 (%) 6 (13.0) 4 (8.7)
Patients with PAM Level 3 (%) 23 (50.0) 20 (43.5)
Patients with PAM Level 4 (%) 14 (30.4) 17 (37.9)
Daily Steps 8312 (7314 to 9571) 8484 (7020 to 9814) 0.734 0.045
Daily Physical Activity Duration (Minutes) 94.7 (81.1 to 109.8) 101.7 (82.0 to 119.0) 0.296 0.100
Body Mass Index (kg.m2) 27.9 (26.4 to 29.5) 27.7 (26.1 to 29.3) 0.126 0.067
Resting Systolic Blood Pressure (mmHg) 125 (120 to 130) 119 (115 to 122) 0.023* 0.445
Resting Diastolic Blood Pressure (mmHg) 75 (71 to 79) 72 (69 to 75) 0.184 0.234
Resting Heart Rate✝ (bpm) 62 (44 to 93) 64 (46 to 87) 0.149 0.053
Waist circumference (cm) 92.8 (82.6 to 102.9) 85.3 (79.1 to 96.2) 0.026* 0.506
PHQ Questionnaire✝ 4.0 (0.0 to 23.0) 2.0 (0.0 to 19.0) 0.619 0.016
GAD Questionnaire✝ 3.0 (0.0 to 21.0) 1.5 (0.0 to 14.0) 0.693 0.010
WSA Scale Score✝ 4.0 (0.0 to 24.0) 1.0 (0.0 to 23.0) 0.906 0.001
TAM2 Score✝ (MET-minutes per week) 1557.5 (245.0 to 5355.0) 3363.2 (105.0 to 12,360.0) < 0.001* 0.419
  1. PAM Patient Activation Measure, PHQ Patient Health Questionnaire, General Anxiety Disorder, WSA Work and Social Adjustment, TAM2 Total Activity Measurement, MET Metabolic Equivalents
  2. ✝ = Non-Parametric Analysis; * significant difference